Slingshot members are tracking this event:

Phase 2 Open-Label Extension Study of EN3835 in the Treatment of Cellulite expected to be complete in June 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ENDP Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 18, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Edematous Fibrosclerotic Panniculopathy, Cellulite